Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Due Diligence in Life Science Transactions, nd Edition' returned 4 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Early Stage and Discovery Deals: Strategy, Structure and Payment Terms, 2nd Edition   Pharmalicensing Ltd., Dec 2006, Pages: 144 a successful player within the life science industry it is crucial to understand the changing dynamics of the industry’s early stage deal-making trends. Our revised second edition of “Early Stage and Discovery Private Equity as an Asset Class, 2nd Edition   John Wiley and Sons Ltd, April 2010, Pages: 280 by Sector. IT. Telecoms. Life Science. Classifi cation by Stage. Seed stage. Early stage. Mid and late stages. Summary. 9 How to Analyse Venture. The Fundamentals (1) – Money Multiples Hedge Funds: Crossing the Institutional Frontier - 2nd Edition   Euromoney Trading Ltd, May 2011, Pages: 262 model approach Tentative segregation of candidate risk factors Operational due diligence Independent administration Independent risk control Managed accounts Conclusion 17 Prime brokers: analysing Executive Report on Strategies in Syrian Arab Republic   ICON Group International, June 2007, Pages: 390 cases.  Languages:  Arabic, French, and some English. Checking Bona Fides There are practically no agencies in Syria that can perform due diligence or provide bona fides services on banks, agents Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network